Intelligent Bio Solutions Inc. (NASDAQ:INBS) Sees Significant Increase in Short Interest

Intelligent Bio Solutions Inc. (NASDAQ:INBS) saw a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 90,000 shares, a growth of 147.3% from the May 31st total of 36,400 shares. Based on an average trading volume of 61,400 shares, the days-to-cover ratio is currently 1.5 days. Currently, 2.9% of the company’s shares are sold short.

Intelligent Bio Solutions Trading Up 2.7 %

NASDAQ:INBS traded up $0.05 on Friday, hitting $1.92. 86,875 shares of the stock were exchanged, compared to its average volume of 1,680,146. The stock has a market cap of $5.99 million, a PE ratio of -0.05 and a beta of 4.75. The company has a current ratio of 2.02, a quick ratio of 1.87 and a debt-to-equity ratio of 0.01. The stock has a fifty day moving average of $2.30 and a 200-day moving average of $3.39. Intelligent Bio Solutions has a fifty-two week low of $1.76 and a fifty-two week high of $39.48.

Intelligent Bio Solutions (NASDAQ:INBS) last posted its earnings results on Wednesday, May 8th. The company reported ($1.43) earnings per share (EPS) for the quarter. Intelligent Bio Solutions had a negative net margin of 354.86% and a negative return on equity of 210.36%. The company had revenue of $0.82 million during the quarter. As a group, equities analysts expect that Intelligent Bio Solutions will post -3.67 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Intelligent Bio Solutions

An institutional investor recently bought a new position in Intelligent Bio Solutions stock. CVI Holdings LLC bought a new stake in Intelligent Bio Solutions Inc. (NASDAQ:INBS) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 108,250 shares of the company’s stock, valued at approximately $457,000. Intelligent Bio Solutions makes up about 0.4% of CVI Holdings LLC’s holdings, making the stock its 27th biggest holding. CVI Holdings LLC owned about 3.81% of Intelligent Bio Solutions as of its most recent filing with the Securities & Exchange Commission. 32.97% of the stock is currently owned by institutional investors.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.